According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “
NHI has been the subject of a number of other research reports. TheStreet upgraded National Health Investors from a c rating to a b- rating in a research report on Wednesday, July 1st. Mizuho lowered National Health Investors from a buy rating to a neutral rating and reduced their target price for the company from $60.00 to $55.00 in a report on Friday, May 22nd. ValuEngine lowered National Health Investors from a hold rating to a sell rating in a report on Thursday, April 2nd. KeyCorp cut their price objective on National Health Investors from $43.00 to $40.00 and set an underweight rating for the company in a report on Thursday, May 14th. Finally, Wells Fargo & Co increased their price objective on National Health Investors from $54.00 to $66.00 and gave the stock an equal weight rating in a report on Wednesday, June 17th. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and one has given a buy rating to the company’s stock. National Health Investors presently has an average rating of Hold and an average target price of $70.14.
Shares of NYSE NHI opened at $62.00 on Wednesday. The stock has a fifty day moving average price of $59.57 and a two-hundred day moving average price of $63.97. The company has a debt-to-equity ratio of 1.03, a quick ratio of 12.05 and a current ratio of 12.05. The firm has a market cap of $2.77 billion, a P/E ratio of 14.73 and a beta of 0.84. National Health Investors has a 1 year low of $31.37 and a 1 year high of $91.12.
National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Monday, May 11th. The real estate investment trust reported $1.37 EPS for the quarter, missing analysts’ consensus estimates of $1.40 by ($0.03). National Health Investors had a net margin of 57.16% and a return on equity of 12.62%. The company had revenue of $83.08 million for the quarter, compared to analyst estimates of $80.77 million. During the same quarter last year, the company posted $1.31 EPS. National Health Investors’s revenue was up 9.2% on a year-over-year basis. On average, research analysts predict that National Health Investors will post 5.61 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Tuesday, June 30th will be issued a $1.102 dividend. This represents a $4.41 dividend on an annualized basis and a dividend yield of 7.11%. The ex-dividend date is Monday, June 29th. National Health Investors’s dividend payout ratio is currently 80.18%.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Botty Investors LLC lifted its position in National Health Investors by 33.9% in the 2nd quarter. Botty Investors LLC now owns 10,160 shares of the real estate investment trust’s stock valued at $628,000 after acquiring an additional 2,575 shares in the last quarter. Brinker Capital Inc. bought a new stake in National Health Investors in the 2nd quarter valued at $244,000. ARP Americas LP bought a new stake in National Health Investors in the 2nd quarter valued at $413,000. Raymond James & Associates lifted its position in National Health Investors by 10.0% during the 2nd quarter. Raymond James & Associates now owns 81,132 shares of the real estate investment trust’s stock worth $4,926,000 after buying an additional 7,406 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in National Health Investors by 61.4% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 29,487 shares of the real estate investment trust’s stock worth $1,790,000 after buying an additional 11,220 shares in the last quarter. 68.92% of the stock is owned by hedge funds and other institutional investors.
About National Health Investors
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
See Also: Trade War
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.